| 1 |
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos et al. · The Lancet
Open access679 authors |
7 Jun 2015 |
6,558 |
| 2 |
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Christopher J L Murray et al. · The Lancet
Open access366 authors |
21 Jul 2014 |
998 |
| 3 |
In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.
S Habu, H Fukui, Kunihiro Shimamura et al. · The Journal of Immunology
|
Jul 1981 |
427 |
| 4 |
European framework for tuberculosis control and elimination in countries with a low incidence
Jaap F. Broekmans, Giovanni Battista Migliori, H. L. Rieder et al. · European Respiratory Journal
Open access |
Apr 2002 |
311 |
| 5 |
The Tuberculosis Cascade of Care in India’s Public Sector: A Systematic Review and Meta-analysis
Ramnath Subbaraman, Ruvandhi R. Nathavitharana, Srinath Satyanarayana et al. · PLoS Medicine
ReviewOpen access |
25 Oct 2016 |
287 |
| 6 |
Community-wide Screening for Tuberculosis in a High-Prevalence Setting
Guy Barrington Marks, Nguyen Viet Nhung, Phuong Thi Bich Nguyen et al. · New England Journal of Medicine
|
2 Oct 2019 |
235 |
| 7 |
Prevalence of SARS-CoV-2 infection in India
ManojV Murhekar et al. · The Indian Journal of Medical Research
Open access |
Jul 2020 |
225 |
| 8 |
Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models
Rein M G J Houben et al. · The Lancet Global Health
Open access |
10 Oct 2016 |
212 |
| 9 |
SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey
Manoj Vasanth Murhekar et al. · The Lancet Global Health
Open access108 authors |
27 Jan 2021 |
210 |
| 10 |
Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial
Anurag Bhargava, Madhavi Bhargava, Ajay Meher et al. · The Lancet
|
Aug 2023 |
197 |
| 11 |
Surveillance of tuberculosis in Europe. Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases
HL Rieder, Judith M. Watson, Mario Carlo Raviglione et al. · European Respiratory Journal
Open access |
May 1996 |
195 |
| 12 |
Measuring tuberculosis burden, trends, and the impact of control programmes
Christopher Dye, Amal Bassili, Ana Luiza Bierrenbach et al. · The Lancet Infectious Diseases
|
29 Jan 2008 |
173 |
| 13 |
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021
Manoj Vasanth Murhekar et al. · International Journal of Infectious Diseases
Open access136 authors |
19 May 2021 |
148 |
| 14 |
Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan
Sabine Hofmann-Thiel, Jakko van Ingen, Kristine Feldmann et al. · European Respiratory Journal
Open access |
Oct 2008 |
138 |
| 15 |
Proteogenomic Analysis of Mycobacterium tuberculosis By High Resolution Mass Spectrometry
Dhanashree S. Kelkar et al. · Molecular & Cellular Proteomics
Open access |
3 Oct 2011 |
131 |
| 16 |
Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India
Anurag Bhargava, Madhavi Bhargava, Ajay Meher et al. · The Lancet Global Health
Open access |
8 Aug 2023 |
123 |
| 17 |
Risk Factors Associated with Default among New Smear Positive TB Patients Treated Under DOTS in India
Sophia Vijay, Prahlad Kumar, Lakbir Singh Chauhan et al. · PLoS ONE
Open access |
6 Apr 2010 |
118 |
| 18 |
Exploring the Complex Connection Between Diabetes and Cardiovascular Disease: Analyzing Approaches to Mitigate Cardiovascular Risk in Patients With Diabetes
FNU Jyotsna, Areeba Ahmed, Kamal Kumar et al. · Cureus
Open access |
21 Aug 2023 |
116 |
| 19 |
Microscopy as a diagnostic tool in pulmonary tuberculosis
Ritu Singhal, Vithal Prasad Myneedu · International Journal of Mycobacteriology
Open access |
2015 |
116 |
| 20 |
Comparison of Enzyme-Linked Immunospot Assay and Tuberculin Skin Test in Healthy Children Exposed to Mycobacterium tuberculosis
Philip C. Hill, Roger H. Brookes, Ifedayo Adetifa et al. · PEDIATRICS
|
May 2006 |
114 |
| 21 |
Guidelines for conducting tuberculin skin test surveys in high-prevalence countries.
Hans L Rieder, Chadha Vk, Nagelkerke Nj et al. · PubMed
|
2011 |
114 |
| 22 |
‘I am on treatment since 5 months but I have not received any money’: coverage, delays and implementation challenges of ‘Direct Benefit Transfer’ for tuberculosis patients – a mixed-methods study from South India
Abhay Subhashrao Nirgude, Ajay M. V. Kumar, Collins Timire et al. · Global Health Action
Open access |
2019 |
95 |
| 23 |
Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models
Nicolas A. Menzies et al. · The Lancet Global Health
Open access |
10 Oct 2016 |
95 |
| 24 |
The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment
Frederick Adriaan Sirgel, Frederik J. H. Botha, Donald P. Parkin et al. · Journal of Antimicrobial Chemotherapy
|
1993 |
91 |
| 25 |
Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional study
Manoj Vasanth Murhekar et al. · PLoS Medicine
Open access |
10 Dec 2021 |
88 |
| 26 |
The Profile and Treatment Outcomes of the Older (Aged 60 Years and Above) Tuberculosis Patients in Tamilnadu, South India
Ramya Ananthakrishnan, Kaliyaperumal Kumar, M T Ganesh et al. · PLoS ONE
Open access |
8 Jul 2013 |
86 |
| 27 |
Effect of Streptomycin on the Incorporation of Amino-Acids labeled with Carbon-14 into Ribonucleic Acid and Protein in a Cell-free System of a Mycobacterium
Thomas Erdos, Agnès Ullmann · Nature
|
Feb 1959 |
85 |
| 28 |
Socio-demographic and AIDS-related factors associated with tuberculosis stigma in southern Thailand: a quantitative, cross-sectional study of stigma among patients with TB and healthy community members
Aaron M. Kipp, Petchawan Pungrassami, Kittikorn Nilmanat et al. · BMC Public Health
Open access |
30 Aug 2011 |
83 |
| 29 |
Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort Analysis
Pranay Sinha et al. · Clinical Infectious Diseases
Open access |
23 Nov 2022 |
82 |
| 30 |
HLA-DR Marks Recently Divided Antigen-Specific Effector CD4 T Cells in Active Tuberculosis Patients
Rashmi Tippalagama et al. · The Journal of Immunology
Open access |
30 Jun 2021 |
81 |
| 31 |
Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation
Muhammad Ali Muzammil, Fnu Fariha, Tirath Patel et al. · Cureus
ReviewOpen access |
28 Jun 2023 |
74 |
| 32 |
Short-course Chemotherapy for Tuberculosis with Largely Twice-weekly Isoniazid-Rifampin
Asim K. Dutt, Lucile S. Jones, William W. Stead · CHEST Journal
|
Apr 1979 |
73 |
| 33 |
A Systematic Review of the Effectiveness of Hospital- and Ambulatory-Based Management of Multidrug-Resistant Tuberculosis
Amal Bassili, Christopher J. Fitzpatrick, Ejaz Qadeer et al. · American Journal of Tropical Medicine and Hygiene
ReviewOpen access |
7 Aug 2013 |
72 |
| 34 |
Relationship between Nutritional Support and Tuberculosis Treatment Outcomes in West Bengal, India
Blesson Samue, Tyson A. Volkmann, Sushma Cornelius et al. · Journal of Tuberculosis Research
Open access |
2016 |
69 |
| 35 |
Molecular and Conventional Epidemiology of Mycobacterium tuberculosis in Botswana: a Population-Based Prospective Study of 301 Pulmonary Tuberculosis Patients
Shahin Lockman, Jeffery D. Sheppard, Christopher R. Braden et al. · Journal of Clinical Microbiology
Open access |
Mar 2001 |
67 |
| 36 |
Inflammasome activation underlies central nervous system deterioration in HIV-associated tuberculosis
Suzaan Marais, Rachel Lai, Katalin Andrea Wilkinson et al. · The Journal of Infectious Diseases
Open access |
16 Nov 2016 |
65 |
| 37 |
Tuberculosis epidemiology in India: a review.
V K Chadha · PubMed
|
Oct 2005 |
63 |
| 38 |
Mycobacterium tuberculosis cords within lymphatic endothelial cells to evade host immunity
Thomas R. Lerner, Christophe J. Queval, Rachel Lai et al. · JCI Insight
Open access |
5 May 2020 |
60 |
| 39 |
Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: a systematic review and meta-analysis of comparative effectiveness
Cameron M. Wright, Lenna M. Westerkamp, Sarah Körver et al. · BMC Infectious Diseases
ReviewOpen access |
7 May 2015 |
59 |
| 40 |
Counting the lives saved by DOTS in India: a model-based approach
Sandip Mandal, Vineet Kumar Chadha, Ramanan Laxminarayan et al. · BMC Medicine
Open access |
20 Feb 2017 |
58 |
| 41 |
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study
Onno W. Akkerman et al. · International Journal of Infectious Diseases
Open access |
3 Apr 2019 |
57 |
| 42 |
TB treatment outcomes among TB-HIV co-infections in Karnataka, India: how do these compare with non-HIV tuberculosis outcomes in the province?
Suresh G. Shastri, Balaji Rama Naik, Anita Shet et al. · BMC Public Health
Open access |
11 Sep 2013 |
56 |
| 43 |
Prevalence of Pulmonary Tuberculosis - A Baseline Survey In Central India
Vikas Gangadhar Rao, Jyothi Bhat, Rajiv Yadav et al. · PLoS ONE
Open access |
29 Aug 2012 |
56 |
| 44 |
The Clinical Features and Bacteriological Characterizations of Bone and Joint Tuberculosis in China
Su-Ting Chen, Li-Ping Zhao, Wei-Jie Dong et al. · Scientific Reports
Open access |
8 Jun 2015 |
55 |
| 45 |
Treatment Outcome and Mortality at One and Half Year Follow-Up of HIV Infected TB Patients Under TB Control Programme in a District of South India
Sophia Vijay, Prahlad Kumar, Lakbir Singh Chauhan et al. · PLoS ONE
Open access |
26 Jul 2011 |
54 |
| 46 |
Prevalence and factors associated with tuberculosis infection in India
Sriram Selvaraju et al. · Journal of Infection and Public Health
Open access |
12 Oct 2023 |
53 |
| 47 |
Appropriate DevR (DosR)-Mediated Signaling Determines Transcriptional Response, Hypoxic Viability and Virulence of Mycobacterium tuberculosis
Shyamasree De Majumdar, Atul Vashist, Sakshi Dhingra et al. · PLoS ONE
Open access |
26 Apr 2012 |
53 |
| 48 |
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
Viola Dreyer et al. · Genome Medicine
Open access |
21 Aug 2022 |
51 |
| 49 |
Average annual risk of tuberculous infection in India.
V K Chadha, Pradeep Kumar, P S Jagannatha et al. · PubMed
|
2005 |
50 |
| 50 |
Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment – Tamil Nadu, India
Karun Sandeep Veesa, Kamalabhai Russell John, Patrick K. Moonan et al. · PLoS ONE
Open access |
7 Feb 2018 |
49 |